Cargando…

Hopamine as Personalized Medicine for Persons with Parkinson’s Disease

Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson’s disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with...

Descripción completa

Detalles Bibliográficos
Autores principales: Noordegraaf, Marina A., van den Berg, Sanne W., Bloem, Bastiaan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041418/
https://www.ncbi.nlm.nih.gov/pubmed/36806516
http://dx.doi.org/10.3233/JPD-230012
_version_ 1784912713121529856
author Noordegraaf, Marina A.
van den Berg, Sanne W.
Bloem, Bastiaan R.
author_facet Noordegraaf, Marina A.
van den Berg, Sanne W.
Bloem, Bastiaan R.
author_sort Noordegraaf, Marina A.
collection PubMed
description Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson’s disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with Parkinson’s disease to draft their own personalized prescription of “hopamine”. The term hopamine is a self-invented neologism representing the uniquely personal set of hopes, desires, experiences, and skills of each individual with a dopamine deficit. As such, the concept of hopamine–as a reflection of the unique personal characteristics of each person with Parkinson’s disease—really supplements that of dopamine–as a reflection of each person’s unique physical characteristics. Whereas a prescription of dopamine replacement medication necessitates the diagnosed individual to lay his or her fate in the hands of medical professionals, adding a personalized dose of hopamine to the therapeutic mix empowers persons to self-manage daily life with Parkinson’s disease. In this viewpoint, we argue that hopamine is a prerequisite for personalized medicine and offer several practical recommendations for how medical professionals can introduce the concept of hopamine in daily clinical practice.
format Online
Article
Text
id pubmed-10041418
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-100414182023-03-28 Hopamine as Personalized Medicine for Persons with Parkinson’s Disease Noordegraaf, Marina A. van den Berg, Sanne W. Bloem, Bastiaan R. J Parkinsons Dis Commentary Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson’s disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with Parkinson’s disease to draft their own personalized prescription of “hopamine”. The term hopamine is a self-invented neologism representing the uniquely personal set of hopes, desires, experiences, and skills of each individual with a dopamine deficit. As such, the concept of hopamine–as a reflection of the unique personal characteristics of each person with Parkinson’s disease—really supplements that of dopamine–as a reflection of each person’s unique physical characteristics. Whereas a prescription of dopamine replacement medication necessitates the diagnosed individual to lay his or her fate in the hands of medical professionals, adding a personalized dose of hopamine to the therapeutic mix empowers persons to self-manage daily life with Parkinson’s disease. In this viewpoint, we argue that hopamine is a prerequisite for personalized medicine and offer several practical recommendations for how medical professionals can introduce the concept of hopamine in daily clinical practice. IOS Press 2023-03-14 /pmc/articles/PMC10041418/ /pubmed/36806516 http://dx.doi.org/10.3233/JPD-230012 Text en © 2023 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Noordegraaf, Marina A.
van den Berg, Sanne W.
Bloem, Bastiaan R.
Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
title Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
title_full Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
title_fullStr Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
title_full_unstemmed Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
title_short Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
title_sort hopamine as personalized medicine for persons with parkinson’s disease
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041418/
https://www.ncbi.nlm.nih.gov/pubmed/36806516
http://dx.doi.org/10.3233/JPD-230012
work_keys_str_mv AT noordegraafmarinaa hopamineaspersonalizedmedicineforpersonswithparkinsonsdisease
AT vandenbergsannew hopamineaspersonalizedmedicineforpersonswithparkinsonsdisease
AT bloembastiaanr hopamineaspersonalizedmedicineforpersonswithparkinsonsdisease